The short answer: every published human study of GHK-Cu put it on the skin. Creams, serums and an eye cream, mostly in women around 50, mostly for 12 weeks. Nobody has published a human trial of injecting it.
So "cream vs injection" isn't a fair fight between two tested options. One has a small, old and mostly cosmetic evidence base. The other has animal studies and a lot of enthusiasm.
Status as of October 24, 2026: GHK-Cu is not an FDA-approved drug for any use. Copper peptide creams are sold legally as cosmetics, which don't need FDA approval. Injectable GHK-Cu has no published human trial, and its nomination for compounding was withdrawn. This post describes what studies measured. It isn't medical advice. Ask your dermatologist what fits your skin.
Want the short version of what's actually approved, legal and tested? Get the free BHN cheat sheet.
GHK-Cu cream vs injection: what's the difference in the evidence?
The cream side has a handful of small human studies. The injection side has none in people. Here's the side-by-side.
Cream or serum | Injection | |
|---|---|---|
Published human trials of GHK-Cu | A handful, mostly small, 1998 to 2026 | None |
Largest study | 71 women, 12 weeks, face cream (2002 conference report) | None |
What was measured | Wrinkles, skin density and thickness, collagen in biopsies, eyebrow hair count | Nothing in people. Studies are in rats, mice, pigs and dogs |
Registered trials now | Two, both on the skin: a wound gel and an anti-aging serum | None |
FDA position | Sold as a cosmetic. No approval needed, as long as it makes no drug claims | Not approved. FDA lists safety concerns for injectable GHK-Cu |
Sources: Pharmaceutics, Aug 2026, Pickart, BioMed Res Int, 2015, ClinicalTrials.gov (searched Oct 24, 2026), FDA.
An independent review published in August searched the whole field and put it plainly: "the clinical evidence remains sparse and does not meet contemporary active-entity quality standards." It called GHK-Cu "a promising but unproven therapeutic cargo rather than a clinically validated regenerative drug" (Pharmaceutics, 2026).
What is GHK-Cu, and what does copper peptide do for skin?
GHK-Cu is a tiny peptide, three amino acids long, holding one copper ion. Your body makes the peptide. On ingredient labels it's usually listed as copper tripeptide-1 (CIR, 2018).
It was found in human blood in 1973 by Loren Pickart (PubMed). His reviews report that blood levels fall from about 200 ng/mL at age 20 to about 80 ng/mL by age 60, and that it stimulated collagen production in lab studies and sped wound repair in animal studies (BioMed Res Int, 2015).
One thing to know before reading those reviews: Pickart wrote most of them, and his listed affiliation is the research department of his own company, which sells copper peptide skin products (Int J Mol Sci, 2018). The reviews declare no conflicts. That doesn't make them wrong. It does mean most of the copper peptide literature runs through one person with a commercial stake.
What copper peptide does for skin in people is a narrower question. The answer is the studies below.
What human studies have been done on GHK-Cu cream?
Six, if you count generously. Only one is in a PubMed-indexed journal.
Study | Who | How long | What it measured | Where it was reported |
|---|---|---|---|---|
Abdulghani, 1998 | Women, cream on the thigh | 1 month | Collagen in skin biopsies, vs vitamin C cream and tretinoin | Small journal, not in PubMed |
Leyden, 2002 | 71 women with sun-damaged facial skin | 12 weeks | Skin looseness, clarity, fine lines, wrinkle depth, skin density and thickness | Dermatology conference report |
Leyden, 2002 | 41 women, eye area | 12 weeks | Lines, wrinkles, skin density, vs placebo and a vitamin K cream | University report, not in a journal |
Finkley, 2005 | 67 women aged 50 to 59 | 12 weeks, twice daily | Similar skin measures plus biopsies | Book chapter |
Miller, 2006 | 13 people after CO2 laser treatment | 12 weeks | Redness, wrinkles, skin quality, by computer and blinded raters | Arch Facial Plast Surg (PubMed) |
Bo, 2026 | 18 healthy adults aged 18 to 40 | 12 weeks, twice daily | Eyebrow hair count and thickness, one brow treated, one placebo | Procedia of Multidisciplinary Research |
Sources: Pickart, 2015 for the first four, Miller, 2006, Bo, 2026. A PubMed search on October 24, 2026 found none of the first four.
The independent review describes the 2002 facial study as "a conference-level cosmetic report rather than a fully reported controlled trial" (Pharmaceutics, 2026). None of these studies reported how much of the copper was actually bound to the peptide, which the review argues matters for any copper peptide product.
GHK-Cu cream before and after: what did the studies actually find?
The positive findings come from the studies that are hardest to check. The best-documented skin study found no measurable difference.
The 2002 face cream study. Per Pickart's summary, the cream improved skin looseness, clarity and appearance, reduced fine lines and wrinkle depth, and increased skin density and thickness in 71 women over 12 weeks (BioMed Res Int, 2015). The full data was never published in a journal.
The eye cream study. Per the same summary, the copper peptide eye cream beat both placebo and a vitamin K cream on lines, wrinkles and skin density in 41 women.
The laser study. After CO2 laser resurfacing, 13 patients used skin care with or without GHK-Cu. Computer analysis and blinded raters found no significant difference in redness, wrinkles or overall skin quality. Patients using GHK-Cu did rate their skin quality higher on a questionnaire (P = .04) (Arch Facial Plast Surg, 2006).
So any "before and after" photo you see online is a marketing image, not a study result. The studies used graders, scales and biopsies, and the one with blinded computer analysis came up empty. More copper peptide studies exist, but they test products with many active ingredients, so they can't tell you what the copper peptide did on its own.
How long does GHK-Cu cream take to work?
The studies ran for 12 weeks, with one collagen biopsy study at 1 month. That's how long they looked, not proof of when anything starts. No study tracked week-by-week change, so nobody can tell you "you'll see it at week 4."
Copper peptide vs retinol, or vs vitamin C: which is better?
No study has compared copper peptide with over-the-counter retinol. The only head-to-head is the small 1998 thigh study.
In it, collagen increased in 70% of women using the copper peptide cream, 50% using a vitamin C cream and 40% using tretinoin, the prescription retinoid (Pickart, 2015, citing Abdulghani, 1998). That's one month, on thigh skin, in a journal PubMed doesn't index. It's not enough to rank them.
What can be said is that copper peptide hasn't been shown to beat or replace either one.
What should not be used with copper peptides?
No study has tested copper peptides alongside other skin care in people. The common advice to keep them apart from vitamin C and strong acids comes from chemistry, not trials.
The August review explains why chemists worry. Which form of GHK-Cu is present depends on pH, and "reducing agents and antioxidants can alter" the copper's state, while chelators and other ingredients can "redistribute copper" away from the peptide (Pharmaceutics, 2026). Vitamin C is a reducing agent, and many acid exfoliants lower pH. So it's a reasonable precaution, not a proven interaction. If you use a prescription retinoid or several actives, ask your dermatologist how to layer them.
Does copper peptide help with hair loss?
Not shown. There's no published controlled trial of GHK-Cu alone for scalp hair loss.
The closest is the 2026 eyebrow study: 18 healthy adults aged 18 to 40 put a 2% GHK-Cu serum on one eyebrow and a placebo serum on the other, twice daily for 12 weeks. Hair count and thickness increased on the treated side, and no serious side effects or allergic reactions were reported (Bo, 2026). That's eyebrows, in young adults, not thinning scalp hair after 50.
The lab study often cited for hair used a different copper peptide, AHK-Cu, on hair follicles in a dish (Arch Pharm Res, 2007). For labels, the FDA says a product that claims to "restore hair growth" is a drug, not a cosmetic (FDA).
What about GHK-Cu injections?
There are no published human trials of injected GHK-Cu. The injection research is in animals.
Pickart's reviews describe animal research in rats, mice, pigs and dogs, including injections in rodents (BioMed Res Int, 2015). A 2026 primer for sports medicine doctors says "no clinical data support its use for musculoskeletal conditions" (Am J Sports Med, 2026). The two registered trials that give people GHK-Cu both put it on the skin: a phase 2 wound gel study and an anti-aging serum study (ClinicalTrials.gov, NCT07888595, searched Oct 24, 2026).
The one human injection study that includes it isn't a GHK-Cu study. A 2018 scalp study injected a mix of six ingredients, one of them copper tripeptide-1, with no comparison group (J Cosmet Laser Ther, 2018). It can't say anything about copper peptide on its own.
The review's main safety question for injections is copper itself. It calls loose, unbound copper "the single most consequential attribute" of these products and flags copper building up in the liver as a long-term concern with repeated injection (Pharmaceutics, 2026). If you've seen people complain that it burns, here's what's known about why GHK-Cu burns.
Copper peptide side effects: can it irritate your skin?
On skin, the safety record is good but thin. A cosmetic safety panel called copper tripeptide-1 safe "in the present practices of use and concentration," noting typical use levels under 10 parts per million (CIR, 2018).
Two caveats:
Copper allergy. The August review notes copper is "a recognized contact sensitizer in susceptible individuals" (Pharmaceutics, 2026). If you react to copper jewelry or have a known metal allergy, ask your dermatologist about a patch test first.
Free copper looks like the bigger irritant. In a skin-cell study, plain copper salts set off irritation markers while GHK-Cu didn't (Sci Rep, 2016). That was cells in a dish, not people.
Stinging, redness that spreads, or a rash that doesn't fade after you stop is a reason to see a dermatologist.
Is GHK-Cu cream legal?
Yes. Copper peptide creams are sold as cosmetics, and the FDA says cosmetics "do not require FDA approval before they go on the market" (FDA).
The line is the claim. A cosmetic can promise to change how skin looks. A product that claims to "regenerate cells" or "restore hair growth" is a drug under the law, and the FDA lists both phrases as examples. The word "cosmeceutical" has no meaning under the law.
Injectable GHK-Cu is a different story:
Not approved as a drug for any use.
Non-injectable GHK-Cu is under FDA review for compounding (Category 1). The injectable nomination was withdrawn (FDA, May 14, 2026).
Injectable GHK-Cu stays on FDA's safety-risk page, which cites possible immune reactions, impurities and "limited data in humans" (FDA).
An FDA advisory committee will review GHK-Cu before the end of February 2027. As of October 24, 2026, FDA's page still lists no date (FDA). The committee hasn't voted on GHK-Cu.
That status is tracked on the compounding status tracker.
So, cream or injection?
On the evidence, only one has been studied in people at all. Copper peptide creams have small, mostly older studies in women around 50, mostly over 12 weeks, with findings that are hard to check and one well-documented study that found no objective difference. Injected GHK-Cu has animal data and no human trials.
If you're curious about a copper peptide cream, treat it like any cosmetic: patch test, give it the 12 weeks the studies used, and ask your dermatologist how it fits with what you already use. For why researchers think the peptide matters beyond skin, see the copper peptide conversation is deeper than cosmetics.
Want the one-page version of what's approved, what's legal and what's actually been tested? Get the free BHN cheat sheet.